Modeling Alzheimer's disease immune therapy mechanisms: Interactions of human postmortem microglia with antibody‐opsonized amyloid beta peptide
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The induction of an antibody response to amyloid beta (Aβ) peptide has become a strategy for the treatment of Alzheimer's disease (AD). This has proven effective in reducing the plaque burden in transgenic mice that develop Aβ plaques similar to human AD patients. The mechanism for enhanced clearance of Aβ is partly due to the interaction of immunoglobulin Fcγ receptor‐expressing microglia and specific antibody‐opsonized Aβ deposits. This interaction can stimulate Fcγ receptor‐mediated phagocytosis, but also results in inflammatory activation of these cells. Consequently, interaction of microglia with antibody‐antigen complexes could exacerbate the existing inflammation in the brains of AD patients. In this study, we used substrate‐bound Aβ and cultured human microglia from AD and non‐demented cases to model interaction of microglia and antibody‐opsonized plaques in AD brains. Enhanced production of tumor necrosis factor‐α, macrophage colony stimulating factor, interleukin‐10, and superoxide ions was detected. We also demonstrated enhanced uptake of opsonized Aβ by microglia, which was reduced significantly in the presence of excess IgG, indicative of the involvement of Fcγ receptor‐mediated mechanisms. Human microglia were shown in this study to express mRNA for Fcγ receptors I, IIa, IIb, and III. The expression of Fcγ receptor II was augmented by proinflammatory stimulation. These results suggest that initial interactions of human microglia with antibody‐opsonized amyloid could result in increased inflammation. The consequence of this on inflammatory pathology in AD brains needs to be considered before immunization is used as a strategy for treating AD. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431 · cited 3×
“…reduction of A plaque formation in plaque-developing transgenic mice, but it was concluded this treatment did not appear to result in exacerbated inflammation in mice (Schenk et al., 1999; Janus et al., 2000; Bard et al., 2000; Morgan et al., 2000; DeMattos et al., 2001; Sigurdsson et al., 2001).”
BackgroundResultMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“As a result of these findings, the use of antiinflammatory drugs as a means of treating AD has become a therapeutic strategy (McGeer et al., 1996).”
BackgroundDeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298 · cited 4×
“…reduction of A plaque formation in plaque-developing transgenic mice, but it was concluded this treatment did not appear to result in exacerbated inflammation in mice (Schenk et al., 1999; Janus et al., 2000; Bard et al., 2000; Morgan et al., 2000; DeMattos et al., 2001; Sigurdsson et al., 2001).”
BackgroundInfluentialImmunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858 · cited 1×
“However, immunization of mice with antibodies to A that did not enter the brain was also effective at preventing the deposition of A into plaques, and in reducing cognitive decline (Dodart et al., 2002; DeMattos et al., 2001).”
BackgroundThe Pathogenesis of Senile Plaques
DICKSON, D. W. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00001 · Cited by 753
DeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M., & Holtzman, D. M. (2002) · Science · doi:10.1126/science.1067568 · Cited by 563
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Self-citationBrain microglia constitutively express β-2 integrins
Akiyama, H., & McGeer, P. L. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90055-r · Cited by 430
Tan, A. S., & Berridge, M. V. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00156-3 · Cited by 330
β-Amyloid Activates the O⨪2 Forming NADPH Oxidase in Microglia, Monocytes, and Neutrophils
Della Bianca, V., Dusi, S., Bianchini, E., Dal Prà, I., & Rossi, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15493 · Cited by 324 · cited 1×
“It has been demonstrated that oxidative damage is already existent in AD-affected brains (Markesbery and Carney, 1999), and that A can induce free radical production by microglial cells through NADPH oxidase activation (Della-Bianca et al., 1999).”
BackgroundRogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236
Self-citationChung, H., Brazil, M. I., Soe, T. T., & Maxfield, F. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32301 · Cited by 212
Van Muiswinkel, F. L., Veerhuis, R., & Eikelenboom, P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062468.x · Cited by 85 · cited 3×
“Van Muiswinkel FL, Veerhuis R, Eikelenboom P. 1996.”
Method
Cited by
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
Beach, T. G., Adler, C. H., Sue, L. I., Serrano, G., Shill, H. A., Walker, D. G., Lue, L., Roher, A. E., Dugger, B. N., Maarouf, C., et al. (2015) · Neuropathology · doi:10.1111/neup.12189 · Cited by 460
Self-citationFang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335
Self-citationMicroglia actions in Alzheimer's disease
Prokop, S., Miller, K. R., & Heppner, F. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1182-x · Cited by 291
“[86], which are viewed with caution in light of severe side effects in initial active vaccination trials, in which unwanted T-cell mediated inflammation occurred [106].”
BackgroundInflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunization
Zotova, E., Bharambe, V., Cheaveau, M., Morgan, W., Holmes, C., Harris, S., Neal, J. W., Love, S., Nicoll, J. A. R., & Boche, D. (2013) · Brain · doi:10.1093/brain/awt210 · Cited by 272
The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007
Beach, T. G., Sue, L. I., Walker, D. G., Roher, A. E., Lue, L., Vedders, L., Connor, D. J., Sabbagh, M. N., & Rogers, J. (2008) · Cell and Tissue Banking · doi:10.1007/s10561-008-9067-2 · Cited by 252
Self-citation
Metadata
- Authors
- Lue, L., & Walker, D. G.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2002-10-25
- Volume
- 70
- Issue
- 4
- Pages
- 599-610
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2022222956
- Cited by
- 56
- References
- 15
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.